Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis of a large clinical trial safety database.
Haematologica
; 109(7): 2277-2283, 2024 07 01.
Article
de En
| MEDLINE
| ID: mdl-38426293
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Pipéridines
/
Pyrazoles
/
Pyrimidines
/
Adénine
Limites:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Haematologica
Année:
2024
Type de document:
Article
Pays de publication:
Italie